Tumor progression in four mammary epithelial cell lines derived from the same patient
- PMID: 1977518
Tumor progression in four mammary epithelial cell lines derived from the same patient
Abstract
Two primary and two metastatic cell lines with distinct phenotypes and genotypes have been established from a patient diagnosed as having infiltrating and intraductal mammary carcinoma (21T series). All four lines can be cultured in the same medium, DFCI-1, which also supports long-term growth of normal epithelial cells. Therefore, we have been able to compare normal and tumor cells at the cellular and molecular levels. The mammary origin of the 21T series was confirmed by using antibodies against the human milk fat globule antigen-2 epitope. The two primary tumor lines (21NT and 21PT) are both immortal and aneuploid, although only 21NT is tumorigenic in the nude mouse assay. The two populations derived from the metastatic pleural effusion (21MT-1 and 21MT-2) each exhibit distinct characteristics in morphology and growth factor requirements. The erbB2 gene is amplified and overexpressed in all of these cell lines compared to normal epithelial cell controls. These four tumor cell lines from a single patient represent a mammary tumor progression series that has been established in long-term cell culture.
Similar articles
-
Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.Cell Growth Differ. 1996 May;7(5):551-61. Cell Growth Differ. 1996. PMID: 8732665
-
Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.Mol Carcinog. 1996 Mar;15(3):227-38. doi: 10.1002/(SICI)1098-2744(199603)15:3<227::AID-MC8>3.0.CO;2-E. Mol Carcinog. 1996. PMID: 8597535
-
Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media.Cancer Res. 1993 Feb 1;53(3):627-35. Cancer Res. 1993. PMID: 8425198
-
Isolation of two distinct epithelial cell lines from a single feline mammary carcinoma with different tumorigenic potential in nude mice and expressing different levels of epidermal growth factor receptors.Cancer Res. 1991 Aug 1;51(15):4028-37. Cancer Res. 1991. PMID: 1649697
-
Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells.Oncogene. 1999 Jul 22;18(29):4237-46. doi: 10.1038/sj.onc.1202799. Oncogene. 1999. PMID: 10435636
Cited by
-
High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer.Proc Natl Acad Sci U S A. 2000 May 23;97(11):6049-54. doi: 10.1073/pnas.100566997. Proc Natl Acad Sci U S A. 2000. PMID: 10811911 Free PMC article.
-
Novel cancer cell lines derived from primary breast tumors in Chinese patients.Am J Transl Res. 2018 Dec 15;10(12):3956-3968. eCollection 2018. Am J Transl Res. 2018. PMID: 30662642 Free PMC article.
-
Malignant transformation of mammary epithelial cells by ectopic overexpression of the aryl hydrocarbon receptor.Curr Cancer Drug Targets. 2011 Jun;11(5):654-69. doi: 10.2174/156800911795655967. Curr Cancer Drug Targets. 2011. PMID: 21486221 Free PMC article.
-
Circadian Alterations Increase with Progression in a Patient-Derived Cell Culture Model of Breast Cancer.Clocks Sleep. 2021 Nov 12;3(4):598-608. doi: 10.3390/clockssleep3040042. Clocks Sleep. 2021. PMID: 34842634 Free PMC article.
-
Explant-cell culture of primary mammary tumors from MMTV-c-Myc transgenic mice.In Vitro Cell Dev Biol Anim. 2004 Jan-Feb;40(1-2):14-21. doi: 10.1290/1543-706X(2004)40<14:ECOPMT>2.0.CO;2. In Vitro Cell Dev Biol Anim. 2004. PMID: 15180438
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous